KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adaptive Biotechnologies (ADPT) Other Non-Current Assets (2018 - 2025)

Historic Other Non-Current Assets for Adaptive Biotechnologies (ADPT) over the last 8 years, with Q3 2025 value amounting to $2.7 million.

  • Adaptive Biotechnologies' Other Non-Current Assets fell 1000.0% to $2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.7 million, marking a year-over-year decrease of 1000.0%. This contributed to the annual value of $2.9 million for FY2024, which is 1924.26% down from last year.
  • As of Q3 2025, Adaptive Biotechnologies' Other Non-Current Assets stood at $2.7 million, which was down 1000.0% from $2.7 million recorded in Q2 2025.
  • In the past 5 years, Adaptive Biotechnologies' Other Non-Current Assets registered a high of $3.6 million during Q4 2023, and its lowest value of $2.1 million during Q1 2021.
  • Moreover, its 5-year median value for Other Non-Current Assets was $2.7 million (2025), whereas its average is $2.7 million.
  • Per our database at Business Quant, Adaptive Biotechnologies' Other Non-Current Assets surged by 4962.5% in 2023 and then plummeted by 2002.95% in 2025.
  • Adaptive Biotechnologies' Other Non-Current Assets (Quarter) stood at $2.1 million in 2021, then grew by 12.25% to $2.4 million in 2022, then skyrocketed by 49.62% to $3.6 million in 2023, then decreased by 19.24% to $2.9 million in 2024, then dropped by 6.9% to $2.7 million in 2025.
  • Its last three reported values are $2.7 million in Q3 2025, $2.7 million for Q2 2025, and $2.7 million during Q1 2025.